Glioblastoma, Recurrent
1 clinical trials · Condition
◉ Watch Glioblastoma, Recurrent
| Record | Firm | Date |
|---|---|---|
| Study of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in Recurrent Gliomas (NCT04267978) | Beijing Sanbo Brain Hospital | 2020-02-13 |
Track Glioblastoma, Recurrent automatically
Every clearance here is in the API, with alerts when new ones post.